ask="N/A"
ask_size="N/A"
average_daily_volume="250993"
bid="9.06"
bid_size="200"
book_value="2.66"
change="-0.08"
change_from_200_day_moving_average="1.01"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-1.14"
change_From_52_week_low="2.93"
change_in_percent="-0.80%"
close="9.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.03"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.73"
ex_dividend_date="N/A"
float_shares="14445000"
high="10.00"
high_52_weeks="11.07"
last_trade_date="2/23/2017"
last_trade_price="9.93"
last_trade_size="10039"
last_trade_time="4:00pm"
low="9.78"
low_52_weeks="7.00"
market_capitalization="181.72M"
moving_average_200_day="8.92"
moving_average_50_day="9.99"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="9.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+11.29%"
percent_change_from_50_day_moving_average="-0.59%"
percent_change_from_52_week_high="-10.30%"
percent_change_from_52_week_low="+41.86%"
previous_close="10.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.77"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="7.05"
stock_exchange="NGM"
symbol="AKBA"
volume="130826"
weeks_range_52="7.00 - 11.07"
